APA (7th ed.) Citation

Hanrahan, E., Ryan, A., Mann, H., Kennedy, S., Langmuir, P., Natale, R., . . . Heymach, J. (2009). Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.

Chicago Style (17th ed.) Citation

Hanrahan, E., A. Ryan, H. Mann, S. Kennedy, P. Langmuir, R. Natale, R. Herbst, B. Johnson, and J. Heymach. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-small Cell Lung Cancer. 2009.

MLA (9th ed.) Citation

Hanrahan, E., et al. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-small Cell Lung Cancer. 2009.